ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Ken Endicottm, Who Led NCI During “Golden Years,” Dies; Helped Establish Chemotherapy, Virology

July 24, 1987

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

New Mechanism – Cancer Control Cooperative Groups – Under Consideration By NCUI For Regional Activities

May 11, 1984